Key Highlights
- Apollo Hospital in New Delhi completes its first patient treatment using ZAP-X.
- The treatment signifies a major advancement in non-invasive brain tumor therapies.
- ZAP-X offers precise tumor targeting, safeguarding healthy brain tissue.
Source: Business Wire
Notable Quotes
- “It perfectly complements our mission to improve patient outcomes and advance the standard of brain tumor treatments,” – Dr. Prathap Reddy, Founder and Chairman at Apollo Hospitals Enterprise Ltd
- “ZAP is honored to support Apollo Hospitals in expanding global access to this potentially life-saving treatment,” – Dr. John R. Adler, CEO at ZAP Surgical Systems, Inc
SoHC's Take
The ZAP-X Gyroscopic Radiosurgery platform represents a leap forward in the treatment of brain tumors. By focusing on non-invasive procedures, this system allows for precise targeting of tumors while preserving the surrounding healthy brain tissue, offering patients a safer alternative with fewer side effects and quicker recovery times compared to traditional methods. The collaboration between ZAP Surgical Systems and Apollo Hospitals marks a significant step in making advanced medical technologies accessible, setting a new benchmark in healthcare innovation. With the ZAP-X system’s distinctive design and operational efficiency, it’s poised to transform the landscape of radiosurgery and offer new hope to millions of patients worldwide.
